Intravenous Ketamine for Treatment-Resistant Depression

NCT06668571 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder, Treatment-Resistant
Treatment Resistant Depression (TRD)

Interventions

DRUG: Ketamine
DRUG: Normal Saline

Sponsor

Mayo Clinic

Collaborators

[object Object]